therapeutic roles curcumin lessons learned clinical trials abstract extensive research past half century shown curcumin diferuloylmethane component golden spice turmeric curcuma longa modulate multiple cell signaling pathways extensive clinical trials past quarter century addressed pharmacokinetics safety efficacy nutraceutical numerous diseases humans promising effects observed patients pro-inflammatory diseases including cancer cardiovascular disease arthritis uveitis ulcerative proctitis crohn disease ulcerative colitis irritable bowel disease tropical pancreatitis peptic ulcer gastric ulcer idiopathic orbital inflammatory pseudotumor oral lichen planus gastric inflammation vitiligo psoriasis acute coronary syndrome atherosclerosis diabetes diabetic nephropathy diabetic microangiopathy lupus nephritis renal conditions acquired immunodeficiency syndrome thalassemia biliary dyskinesia dejerine-sottas disease cholecystitis chronic bacterial prostatitis curcumin shown protection hepatic conditions chronic arsenic exposure alcohol intoxication dose-escalating studies safety curcumin doses high num g/day num months curcumin pleiotropic activities emanate ability modulate numerous signaling molecules pro-inflammatory cytokines apoptotic proteins nf cyclooxygenase num lox stat num c-reactive protein prostaglandin num prostate-specific antigen adhesion molecules phosphorylase kinase transforming growth factor triglyceride num creatinine ho num ast alt human participants clinical trials curcumin combination agents formulations curcumin including nanoparticles liposomal encapsulation emulsions capsules tablets powder examined review discuss detail human diseases effect curcumin investigated 
